Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
INDUSTRY
×
Carcinoma
×
cabozantinib
×
Clear all
Filters
3
NCT07227402
2026-03-16
LITESPARK-033
Merck Sharp & Dohme LLC
Phase 3
Recruiting
904 enrolled
NCT03755791
2025-12-11
COSMIC-312
Exelixis
Phase 3
Active not recruiting
837 enrolled
14 charts
NCT03937219
2025-09-10
COSMIC-313
Exelixis
Phase 3
Active not recruiting
855 enrolled
12 charts
NCT04151563
2023-12-19
CheckMate 79X
Bristol-Myers Squibb
Phase 1/2
Withdrawn